A fresh new start here @bsky.app🦋! Looking forward to connecting with fellow enthusiasts in #CancerImmunology, #Immunotherapy, #CellTherapy, #EarlyPhaseTrials & #TranslationalResearch, amongst other interests in advancing cancer care for patients.

Please feel free to share #StarterPack & say hi! 😀

#ESMOTATAsia25: Presentations highlight the value of integrating #PatientReportedOutcomes (#PRO) into #EarlyPhaseTrials with guidance on standardisation.

Read more in the #ESMODailyReporter

🔗 dailyreporter.esmo.org/esmo-targete...

⏰ Less than 1 week left to submit your abstract to #ESMOTATAsia25. Let's accelerate the development of #earlyphasetrials in the region together.

👉 Submit your research by 29 April by 18:00 Hong Kong Time

🔗 buff.ly/nlzr3GY

We're kicking off today’s ECMC Annual Network Meeting! We’re live with a full agenda focused on innovation, collaboration, and equity in early phase cancer trials. #ECMC2025 #EarlyPhaseTrials